Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$3.83
+1.1%
$3.58
$2.36
$5.77
$4.10M2.56123,149 shs28,385 shs
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
$0.93
+2.4%
$2.69
$0.67
$16.25
$2.34M1.751.59 million shs457,816 shs
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
$0.76
$0.17
$6.77
$1.69M1.551.44 million shs8.72 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%0.00%
HeartSciences Inc. stock logo
HSCS
HeartSciences
+1.06%+2.96%-3.28%+30.10%-30.99%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
+2.39%+2.96%-17.26%-76.12%-88.84%
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
1.8761 of 5 stars
3.53.00.00.00.00.01.3
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.0633 of 5 stars
0.02.00.00.00.00.00.6
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
0.00
N/AN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
3.00
Buy$13.00239.43% Upside
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.00
N/AN/AN/A
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
HeartSciences Inc. stock logo
HSCS
HeartSciences
$20K206.82N/AN/A$11.16 per share0.34
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
$2.56M0.93N/AN/A$1.84 per share0.50
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
$81.98M0.00N/AN/A($3.81) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$6.61M-$7.48N/AN/AN/AN/A-178.80%-109.28%8/4/2025 (Estimated)
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
-$3.70M-$13.53N/AN/A-210.82%-54.73%-38.63%8/13/2025 (Estimated)
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
-$54.60M-$8.12N/AN/AN/A-64.63%-983.11%-74.49%N/A

Latest SRGA, CFMS, HSCS, and NAOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/A-$3.98N/A-$3.98N/A$1.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/AN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/AN/AN/AN/AN/A
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/A
1.02
0.83
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/A
0.47
0.22
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
N/A
2.67
2.00

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
HeartSciences Inc. stock logo
HSCS
HeartSciences
17.24%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
16.39%
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
26.31%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
HeartSciences Inc. stock logo
HSCS
HeartSciences
1.80%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
7.00%
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
3.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
HeartSciences Inc. stock logo
HSCS
HeartSciences
101.08 million1.06 millionNot Optionable
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
202.58 million2.40 millionNot Optionable
Surgalign Holdings, Inc. stock logo
SRGA
Surgalign
2179.24 million8.96 millionOptionable

Recent News About These Companies

Surgalign Holdings Inc.
Surgalign Holdings Inc (SRGAQ)
RT20.BE - SURGALIGN HLDGS NEW -,001
Why Is Surgalign Holdings (SRGA) Stock Up 10% Today?
Short Volatility Alert: Surgalign Holdings
Why Is Surgalign (SRGA) Stock Down 55% Today?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Conformis stock logo

Conformis NASDAQ:CFMS

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

HeartSciences stock logo

HeartSciences NASDAQ:HSCS

$3.83 +0.04 (+1.06%)
Closing price 06/24/2025 04:00 PM Eastern
Extended Trading
$3.76 -0.08 (-1.96%)
As of 06/24/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Nanovibronix stock logo

Nanovibronix NASDAQ:NAOV

$0.93 +0.02 (+2.39%)
Closing price 06/24/2025 04:00 PM Eastern
Extended Trading
$0.92 0.00 (-0.40%)
As of 04:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Surgalign stock logo

Surgalign NASDAQ:SRGA

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. On June 19, 2023, Surgalign Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.